Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03586544 · ClinicalTrials.gov registry record · Phase 4
Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity
A Phase 4 study, sponsored by University of Nevada, Las Vegas.
- Terminated
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
NCT03586544 is a Phase 4 study that was terminated before completion, run by University of Nevada, Las Vegas. The registered enrollment target is 34 participants.
The verdict
NCT03586544, a Phase 4 study, was terminated before completion, sponsored by University of Nevada, Las Vegas.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
Study Summary
Guidelines from the American Thoracic Society strongly recommend interval warm-up exercise before planned exercise to reduce exercise-induced bronchoconstriction severity. However, no empirical data on the effects of interval warm-up exercise on exercise-induced bronchoconstriction severity are available in obese asthmatic children, where excess fat exerts such an unfavorable burden on the respiratory system, particularly during exercise. The objective of this study is to investigate the effects of interval warm-up exercise on exercise-induced bronchoconstriction severity in obese and nonobese asthmatic children. Our approach will be to investigate exercise tolerance, respiratory function, and exercise-induced bronchoconstriction severity and the effects of (1) 8x30sec interval warm-up \& (2) pretreatment with a bronchodilator compared with a no-treatment control on exercise-induced bronchoconstriction severity in 8-12 yr, prepubescent, obese and nonobese asthmatic children. \[Aim\]: To investigate the effects of interval warm-up exercise on exercise-induced bronchoconstriction severity. \[Hypothesis\]: Interval warm-up exercise will reduce exercise-induced bronchoconstriction severity after an exercise challenge test to a similar extent as bronchodilator and better than control.
Interventions
- DRUG Albuterol Sulfate
- BEHAVIORAL Interval Warm-up exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2018-09-18 |
| Est. Completion | 2021-03-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03586544
The ClinicalTrials.gov registry entry for NCT03586544 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nevada, Las Vegas, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Albuterol Sulfate is the first listed.
NCT03586544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03586544 about?
NCT03586544 is a clinical study titled "Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity". Guidelines from the American Thoracic Society strongly recommend interval warm-up exercise before planned exercise to reduce exercise-induced bronchoconstriction severity. However, no empirical data on the effects of interval warm-up exercise on exercise-induced bronchoconstriction severity are avai...
What is the current status of trial NCT03586544?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2018-09-18. Estimated completion is 2021-03-30.
What interventions are being tested in trial NCT03586544?
The interventions under investigation include: Albuterol Sulfate (DRUG), Interval Warm-up exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT03586544?
This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.